SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001104659-15-030854
Filing Date
2015-04-28
Accepted
2015-04-28 11:42:50
Documents
2
Group Members
NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC.

Document Format Files

Seq Description Document Type Size
1 SC 13G a15-10081_1sc13g.htm SC 13G 98201
2 GRAPHIC g100811bci001.jpg GRAPHIC 30974
  Complete submission text file 0001104659-15-030854.txt   142692
Mailing Address LICHTSTRASSE 35 BASEL V8 CH 4056
Business Address LICHTSTRASSE 35 BASEL V8 CH 4056 01141613241111
NOVARTIS AG (Filed by) CIK: 0001114448 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13G
SIC: 2834 Pharmaceutical Preparations

Mailing Address 626 BANCROFT WAY SUITE 3-C BERKELEY CA 94710
Business Address 626 BANCROFT WAY SUITE 3-C BERKELEY CA 94710 510-848-4400
ADURO BIOTECH, INC. (Subject) CIK: 0001435049 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SC 13G | Act: 34 | File No.: 005-88812 | Film No.: 15797373
SIC: 2834 Pharmaceutical Preparations